BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35673241)

  • 1. Prescribing Trends Psychotropic Drugs Against Children and Adolescents and Association with Polypharmacy Reduction Policy for Psychotropic Drugs: Based on Japanese National Database Survey.
    Park J; Okui T; Nakashima N
    Stud Health Technol Inform; 2022 Jun; 290():1132-1133. PubMed ID: 35673241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in Prescription of Psychotropic Drugs After Introduction of Polypharmacy Reduction Policy in Japan Based on a Large-Scale Claims Database.
    Hirano Y; Ii Y
    Clin Drug Investig; 2019 Nov; 39(11):1077-1092. PubMed ID: 31399894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of medical service fee revision on reducing irrational psychotropic polypharmacy in Japan: an interrupted time-series analysis.
    Okada Y; Akazawa M
    Soc Psychiatry Psychiatr Epidemiol; 2022 Feb; 57(2):411-422. PubMed ID: 34333670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of medical fee revisions for psychotropic polypharmacy in patients with mood disorders in Japan: An interrupted time-series analysis using a nationwide inpatient database.
    Yamazaki R; Ohbe H; Matsuda Y; Kito S; Shigeta M; Morita K; Matsui H; Fushimi K; Yasunaga H
    Asian J Psychiatr; 2023 Jun; 84():103581. PubMed ID: 37086613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Extrapyramidal Syndromes Associated With Psychotropic Polypharmacy: A Study Based on Large-Scale Japanese Claims Data.
    Hirano Y
    Ther Innov Regul Sci; 2020 Mar; 54(2):259-268. PubMed ID: 31933179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.
    Hu J; McMillan SS; Theodoros T; Collins JC; El-Den S; O'Reilly CL; Wheeler AJ
    BMC Psychiatry; 2022 Nov; 22(1):705. PubMed ID: 36380352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polypharmacy in children and adolescents initiating antipsychotic drug in 2008-2016: a nationwide register study.
    Varimo E; Saastamoinen LK; Rättö H; Aronen ET
    Nord J Psychiatry; 2023 Jan; 77(1):14-22. PubMed ID: 35263210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and the trajectory of psychotropic medication use in general and antipsychotics in particular among adults with an intellectual disability who exhibit aggressive behaviour.
    Deb S; Unwin G; Deb T
    J Intellect Disabil Res; 2015 Jan; 59(1):11-25. PubMed ID: 24450426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth in the concurrent use of antipsychotics with other psychotropic medications in Medicaid-enrolled children.
    Kreider AR; Matone M; Bellonci C; dosReis S; Feudtner C; Huang YS; Localio R; Rubin DM
    J Am Acad Child Adolesc Psychiatry; 2014 Sep; 53(9):960-970.e2. PubMed ID: 25151419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychotropic Prescribing Practices for Children and Adolescents with Intellectual Disabilities: A Cohort Study Using a Large-scale Health Insurance Database].
    Inoue Y; Okumura Y; Fujita J
    Seishin Shinkeigaku Zasshi; 2016; 118(11):823-833. PubMed ID: 30620838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the trends of polypharmacy and high-dose prescriptions in Japan.
    Shinfuku N
    Asia Pac Psychiatry; 2022 Mar; 14(1):e12488. PubMed ID: 34519433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic drug prescribing survey in a Canadian rehabilitation and complex care facility.
    Warnock CA; Ferguson ID; Lam J
    Consult Pharm; 2014 Jun; 29(6):387-99. PubMed ID: 25202892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic drug and polypharmacy use among adolescents and young adults: findings from the Finnish 1981 Nationwide Birth Cohort Study.
    Gyllenberg D; Sourander A
    Nord J Psychiatry; 2012 Oct; 66(5):336-42. PubMed ID: 22212103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Factors Affecting the Use of Antipsychotics and Antipsychotic Polypharmacy in a Child and Adolescent Psychiatry Inpatient Service.
    Büber A; Gavcar EG; Başay Ö; Ünlü G; Kabukçu Başay B; Şenol H
    J Child Adolesc Psychopharmacol; 2023 Mar; 33(2):69-75. PubMed ID: 36944095
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in psychotropic polypharmacy and high-potency prescription following policy change: Findings from a large scale Japanese claims database.
    Takeshima M; Enomoto M; Ogasawara M; Kudo M; Itoh Y; Yoshizawa K; Fujiwara D; Takaesu Y; Mishima K
    Psychiatry Clin Neurosci; 2022 Sep; 76(9):475-477. PubMed ID: 35655425
    [No Abstract]   [Full Text] [Related]  

  • 17. Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics.
    Yang SY; Chen LY; Najoan E; Kallivayalil RA; Viboonma K; Jamaluddin R; Javed A; Hoa DTQ; Iida H; Sim K; Swe T; He YL; Park Y; Ahmed HU; De Alwis A; Chiu HF; Sartorius N; Tan CH; Chong MY; Shinfuku N; Lin SK
    Psychiatry Clin Neurosci; 2018 Aug; 72(8):572-579. PubMed ID: 29761577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
    Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
    Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
    [No Abstract]   [Full Text] [Related]  

  • 19. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
    Comer JS; Olfson M; Mojtabai R
    J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends.
    Girand HL; Litkowiec S; Sohn M
    Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32487590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.